v3.26.1
Consolidated Statements of Operations (unaudited) - USD ($) |
3 Months Ended | 6 Months Ended | ||
|---|---|---|---|---|
Jun. 30, 2026 |
Jun. 30, 2025 |
Jun. 30, 2026 |
Jun. 30, 2025 |
|
| OPERATING EXPENSES | ||||
| Research and development | $ 6,074,436 | $ 2,499,498 | $ 13,426,159 | $ 3,808,653 |
| General and administrative | 2,501,176 | 2,339,230 | 5,317,391 | 6,029,561 |
| Loss from operations | (8,575,612) | (4,838,728) | (18,743,550) | (9,838,214) |
| OTHER (EXPENSE) INCOME | ||||
| Interest income | 46 | 64 | 91 | 130 |
| Interest expense | (5,581) | (80,925) | ||
| Non-operating expenses | (51,239) | (204,833) | ||
| Change in fair value of warrant liability | 302,042 | 1,424,603 | ||
| TOTAL OTHER (EXPENSE) INCOME | (56,774) | 302,106 | (285,667) | 1,424,733 |
| NET LOSS | (8,632,386) | (4,536,622) | (19,029,217) | (8,413,481) |
| NET LOSS available to common shareholders | $ (8,632,386) | $ (4,536,622) | $ (19,029,217) | $ (8,413,481) |
| Weighted-average # of shares (in Shares) | 43,904,159 | 25,114,460 | 41,356,412 | 25,062,494 |
| Basic loss per common share outstanding (in Dollars per share) | $ (0.2) | $ (0.19) | $ (0.46) | $ (0.35) |
| Diluted loss per common share outstanding (in Dollars per share) | $ (0.2) | $ (0.19) | $ (0.46) | $ (0.35) |
| X | ||||||||||
- Definition The amount of net income (loss) for the period per each share of common stock or unit outstanding during the reporting period. Reference 1: http://www.xbrl.org/2003/role/disclosureRef
|
| X | ||||||||||
- Definition The amount of net income (loss) for the period available to each share of common stock or common unit outstanding during the reporting period and to each share or unit that would have been outstanding assuming the issuance of common shares or units for all dilutive potential common shares or units outstanding during the reporting period. Reference 1: http://www.xbrl.org/2003/role/disclosureRef
|
| X | ||||||||||
- Definition Amount of expense (income) related to adjustment to fair value of warrant liability. Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef
|
| X | ||||||||||
- Definition The aggregate total of expenses of managing and administering the affairs of an entity, including affiliates of the reporting entity, which are not directly or indirectly associated with the manufacture, sale or creation of a product or product line. Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef
|
| X | ||||||||||
- Definition Amount of interest expense classified as nonoperating. Reference 1: http://www.xbrl.org/2003/role/disclosureRef
|
| X | ||||||||||
- Definition Amount before accretion (amortization) of purchase discount (premium) of interest income on nonoperating securities. Reference 1: http://www.xbrl.org/2003/role/disclosureRef
|
| X | ||||||||||
- Definition The portion of profit or loss for the period, net of income taxes, which is attributable to the parent. Reference 1: http://www.xbrl.org/2003/role/disclosureRef
|
| X | ||||||||||
- Definition Amount, after deduction of tax, noncontrolling interests, dividends on preferred stock and participating securities; of income (loss) available to common shareholders. Reference 1: http://www.xbrl.org/2003/role/disclosureRef
|
| X | ||||||||||
- Definition The aggregate amount of income or expense from ancillary business-related activities (that is to say, excluding major activities considered part of the normal operations of the business). Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef
|
| X | ||||||||||
- References No definition available.
|
| X | ||||||||||
- References No definition available.
|
| X | ||||||||||
- Definition The net result for the period of deducting operating expenses from operating revenues. Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef
|
| X | ||||||||||
- Definition Amount of expense related to nonoperating activities, classified as other. Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef
|
| X | ||||||||||
- Definition Amount of expense for research and development. Includes, but is not limited to, cost for computer software product to be sold, leased, or otherwise marketed and writeoff of research and development assets acquired in transaction other than business combination or joint venture formation or both. Excludes write-down of intangible asset acquired in business combination or from joint venture formation or both, used in research and development activity. Reference 1: http://www.xbrl.org/2003/role/disclosureRef
|
| X | ||||||||||
- Definition The average number of shares or units issued and outstanding that are used in calculating diluted EPS or earnings per unit (EPU), determined based on the timing of issuance of shares or units in the period. Reference 1: http://www.xbrl.org/2003/role/disclosureRef
|